Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation
Condition(s):Non-valvular Atrial Fibrillation (NVAF)Last Updated:December 8, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Non-valvular Atrial Fibrillation (NVAF)Last Updated:December 8, 2022Completed
Condition(s):Patients Receiving Rivaroxaban TreatmentLast Updated:February 14, 2017Completed
Condition(s):Venous Thromboembolism; Anticoagulant-induced Bleeding; Venous Thromboses; Pulmonary EmbolismLast Updated:August 25, 2022Completed
Condition(s):Venous ThromboembolismLast Updated:October 6, 2023Recruiting
Condition(s):Acute Coronary Syndrome; Myocardial Infarction; Myocardial Ischemia; Unstable AnginaLast Updated:February 22, 2022Completed
Condition(s):Pulmonary EmbolismLast Updated:August 26, 2020Not yet recruiting
Condition(s):Atrial FibrillationLast Updated:August 3, 2022Completed
Condition(s):Venous Thrombosis; Pulmonary Embolism; Atrial Fibrillation; Acute Coronary SyndromeLast Updated:October 22, 2021Completed
Condition(s):Venous ThrombosisLast Updated:January 18, 2017Completed
Condition(s):HealthyLast Updated:September 9, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.